Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ainhoa Erce-Llamazares
Institutions:
Research Institute Hospital 12 de Octubre,
Hospital Universitario 12 De Octubre
Observed institutions:
Research Institute Hospital 12 de Octubre,
Hospital Universitario 12 De Octubre
ORCID:
0000-0002-3656-1913
Observed ORCID:
0000-0002-3656-1913
OpenAlex ID:
A5015995139
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
2018
·
Marta Compte
, Seandean Lykke Harwood
, et al.
·
Nature Communications
·
153
PDF
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
2022
·
Belén Blanco
, Ángel Ramírez-Fernández
, et al.
·
Cancer Immunology Research
·
35
PDF
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2021
·
Marta Compte
, Seandean L. Harwood
, et al.
·
Clinical Cancer Research
·
30
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response
2023
·
Laura Rubio-Pérez
, Rodrigo Lázaro-Gorines
, et al.
·
OncoImmunology
·
20
Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity
2022
·
Oana Hangiu
, Marta Compte
, et al.
·
iScience
·
18
PDF
Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primates
2024
·
Rocío Navarro
, Susana Frago
, et al.
·
Toxicology and Applied Pharmacology
·
6
Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
2023
·
Belén Blanco
, Ángel Ramírez-Fernández
, et al.
Supplementary Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
2023
·
Belén Blanco
, Ángel Ramírez-Fernández
, et al.
Supplementary Methods from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S6 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S8 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S13 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S4 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S7 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S3 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S1 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S5 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S6 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S1 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Table S4 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S9 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S2 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S11 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S10 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S2 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Show more works
View as search
Works count:
49
Citation count:
262
H-index:
6
I10-index:
5
Year
Topic
Type